SureTrader Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 4/27/2016 6:52:36 PM - Followers: 43 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GALT
Current Price
Volume:
Bid Ask Day's Range
Wiki
SureTrader
GALT News: Amended Annual Report (10-k/a) 04/29/2016 10:00:32 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 04/21/2016 07:36:24 PM
GALT News: Statement of Changes in Beneficial Ownership (4) 04/21/2016 05:09:59 PM
GALT News: Galectin Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference 04/07/2016 12:11:15 PM
GALT News: Galectin Therapeutics Reports 2015 Financial Results and Provides Business Update 03/15/2016 08:00:00 AM
PostSubject
#2151   They most likely sold the shares for tax biotech2010 04/27/16 06:52:36 PM
#2150   Yes it's only about 1.3% of the 10x DirectionalDriller 04/27/16 06:27:58 PM
#2149   And still hold well over 3M shares. Immaterial. Adi2 04/27/16 04:38:50 PM
#2148   The 10x fund sold 44312 shares on April DirectionalDriller 04/27/16 10:43:30 AM
#2147   Interesting chart, thanks for posting it and hopefully biotech2010 04/25/16 09:17:14 AM
#2146   GALT chart Wedge if it completes GALT could dude iligence 04/25/16 12:20:52 AM
#2145   Galmed is working on an oral delivery product IRAHopeful 04/07/16 12:37:53 PM
#2144   I don't post on other boards much but Darwinian 04/07/16 12:23:20 AM
#2143   Presentation: http://wsw.com/webcast/roth30/galt/index.aspx Adi2 03/16/16 07:32:23 AM
#2142   maybe headed to the 100day/av at 1.88.... Chance 03/03/16 07:18:24 AM
#2140   pulm fibrosis patent ? oldsport 02/24/16 11:31:38 AM
#2137   Need to issue more than 500,000 shares just rickyricks 01/26/16 09:04:28 AM
#2136   The stock is a laughingstock. Traber is highly rickyricks 01/26/16 09:00:34 AM
#2135   During this month (Jan, 7 and Jan.21, 2016) JERZYATP1 01/25/16 07:04:38 PM
#2132   Thanks for your thoughtful posts lately JerrzyATP (yes, Darwinian 01/19/16 10:54:17 AM
#2129   As tempting as it is to reiterate why thefamilyman 01/13/16 10:36:57 PM
#2128   Fair enough. In any event the quality of JERZYATP1 01/13/16 10:08:29 PM
#2127   Good for you! Regardless, I sincerely hope thefamilyman 01/11/16 03:37:28 PM
#2126   Musings on executive change (Chairman). As usual a JERZYATP1 01/11/16 03:10:47 PM
#2125   It could be that the BOD has recognized thefamilyman 01/09/16 06:38:11 PM
#2124   I am glad to see the Board of thefamilyman 01/08/16 09:18:41 PM
#2123   Could it be that the flawed leadership I thefamilyman 01/08/16 03:59:33 PM
#2122   A little "house cleaning"/reorg. going on. How much Darwinian 01/08/16 03:21:32 PM
#2121   cool story bro... oldsport 01/05/16 11:56:27 AM
#2120   I reallydon't know what the decision means but rickyricks 01/05/16 09:51:34 AM
#2119   Lawsuits Dismissed, let the share price recovery begin! biotech2010 01/05/16 09:17:56 AM
#2117   Biotech 2010 galectin is going way south. rickyricks 12/06/15 03:33:35 PM
#2116   The lawsuit needs to be wrapped up. Get rickyricks 11/28/15 12:49:36 PM
#2115   Not a good financing deal but obviously the biotech2010 11/27/15 11:26:03 AM
#2114   Thanks for the private message. I'm still holding Darwinian 11/26/15 12:18:12 AM
#2113   2 weeks ago Galt stated enough cash rickyricks 11/22/15 05:22:17 AM
#2112   Yeah. If it were a complete failure it Darwinian 11/21/15 04:09:59 PM
#2111   nonsense talkin... dosage was the main issue in oldsport 11/21/15 04:05:06 PM
#2110   This financing is of a very sic & Adi2 11/21/15 01:31:31 PM
#2109   Traber and Czzir do not have the leadership thefamilyman 11/21/15 12:17:19 PM
#2108   Yes Phase 1 was successful. GALT does not thefamilyman 11/21/15 12:02:59 PM
#2107   Sheesh...GALT must have stopped paying them (joking). That's Darwinian 11/21/15 10:37:10 AM
#2106   don t worry... be happy... oldsport 11/20/15 01:05:10 PM
#2105   Here is the blurb from BTA. The key thefamilyman 11/20/15 12:34:15 PM
#2104   Yes. Another 35% dilution is coming our way. thefamilyman 11/20/15 11:29:36 AM
#2103   wow... major news out and it s dead here... oldsport 11/20/15 09:56:25 AM
#2102   New PR out. ClinicalTrials.gov has the primary thefamilyman 10/19/15 12:33:51 PM
#2101   Galectin Therapeutics' Executive Chairman to Discuss Silent Epidemic candeeman 10/07/15 06:05:35 PM
#2100   Riding the "REGENERATE" wave today. Oh well, something's Darwinian 09/29/15 01:47:09 PM
#2099   H.C. Wainwright Starts Galectin Therapeutics (GALT) at Buy, biotech2010 09/21/15 09:37:27 AM
#2098   I guess there just aren't many for sale. Darwinian 09/17/15 06:41:22 PM
#2097   Jeebus you're fast! Darwinian 09/17/15 05:52:01 PM
#2096   GALTU & GALTW starbuxsux 09/17/15 05:49:22 PM
#2095   What you talkin' bout starbux? Darwinian 09/17/15 05:48:12 PM
#2094   GALT WARRANTS HAVE BEEN INSANE THIS MONTH! starbuxsux 09/17/15 03:30:54 PM
PostSubject